COMMUNIQUÉS West-GlobeNewswire

CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia
02/12/2025
Clermont-Ferrand (France), 2 December 2025 (8:45 AM CET). In line with the commitment signed on November 6, 2025 1 , CARBIOS (Euronext Growth Paris: ALCRB) and Wankai New Materials (« Wankai »), a listed subsidiary 2 of [...]
CARBIOS et Wankai New Materials signent l’accord définitif constitutif d’un partenariat stratégique pour déployer à très grande échelle la technologie de biorecyclage du PET de CARBIOS en Asie
02/12/2025
Clermont-Ferrand (France), 2 décembre 2025 (08h45 CET). Conformément à l’engagement signé le 6 novembre 2025 1 , CARBIOS (Euronext Growth Paris : ALCRB) et Wankai New Materials (« Wankai »), une filiale cotée 2 du [...]
Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial
02/12/2025
EO2401 in vivo immune therapy + nivolumab +/- bevacizumab shows survival benefit in first recurrent glioblastoma Data presented at 2025 SNO conference by lead investigator Paris, France – 2 DECEMBER 2025 (08:30 CET) [...]
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
02/12/2025
COPENHAGEN, Denmark, December 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12 months. This [...]
Tecan expands robotic workcell offering with acquisition of Wako Automation assets
02/12/2025
Männedorf, Switzerland, December 2, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced the acquisition of Wako Automation assets, including the flagship Director™ scheduling software and select hardware [...]
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion
02/12/2025
Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion Schlieren (Zürich), Switzerland, December 2, 2025 – Kuros [...]
Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis)
02/12/2025
The point-of-care test delivers PCR-accurate results in just 15 minutes, enabling healthcare providers to act quickly and prevent severe complications and onward transmission. Detects and differentiates between three [...]
eDrugstore Partners with Groupon for Exclusive Black Friday and Cyber Monday Deals
02/12/2025
SCOTTSDALE, Ariz., Dec. 02, 2025 (GLOBE NEWSWIRE) -- eDrugstore, the parent company of eDrugstore.com, has partnered with Groupon to offer up to 95% off select men’s health products and telehealth services during Black [...]
Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares
02/12/2025
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
Message from the CEO to MediciNova Shareholders
02/12/2025
Strengthening MN-001’s Scientific Foundation and Clinical Outlook LA JOLLA, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Dear Fellow Shareholders, Following the recent publication in the Journal of Atherosclerosis and [...]
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore
01/12/2025
TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“ COSCIENS ” or the “ Company ”), a life sciences company focused on pharmaceutical therapies, diagnostic products [...]
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
01/12/2025
PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and [...]
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
01/12/2025
Webinar to be held Tuesday, December 2nd, at 8:00 am ET REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper or the Company), a clinical stage biotechnology company [...]
Receipt of Delinquency Notification from Nasdaq
01/12/2025
Singapore, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that the Company’s annual report on Form 20-F for the [...]
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
01/12/2025
Company Announcement COPENHAGEN, Denmark; December 1, 2025 – Genmab A/S (Nasdaq: GMAB) – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares
01/12/2025
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients on Wednesday, December 3, 2025
01/12/2025
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it [...]
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
01/12/2025
SAN CARLOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it has been [...]
Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting
01/12/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN [...]

Pages